Literature DB >> 16047518

Reliability and validity of the Functional Assessment of Cancer Therapy General (FACT-G) in French cancer patients.

Nathalie Costet1, Valérie Lapierre, Ellen Benhamou, Catherine Le Galès.   

Abstract

This report describes the reliability and validity of a French version of the Functional Assessment of Cancer Therapy - General (FACT-G) with a French sample of 493 cancer patients. The FACT-G consists of 27 items and four subscales: Physical (PWB), Functional (FWB), Social/Family (SFWB) and Emotional well-being (EWB). The study sample includes 64% with localized disease, 26% with metastases, 11% in remission, and 71% receiving radiation/chemotherapy. Internal consistency Cronbach alphas of the global FACT-G scale (0.90) and subscales (>0.75) are satisfactory (n = 126). Test-retest reproducibility is satisfactory for all subscales and the global scale (n = 87 to 93, r = 0.74 to 0.90). ANOVA models show that PWB differentiated between the three disease stages; the global FACT-G and FWB discriminated between patients with metastases and others with localized disease or in remission; EWB only discriminated between metastases and localized disease; while SFWB did not discriminate between groups at different stages of cancer. Only the PWB subscale discriminated between patients with no history from those receiving chemotherapy (p < or = 0.05). None of the scales discriminated between groups based on radiotherapy. These results may be useful in the design and interpretation of clinical trials involving French patients when the FACT-G is the outcome measure.

Entities:  

Mesh:

Year:  2005        PMID: 16047518     DOI: 10.1007/s11136-004-5531-z

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  18 in total

1.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation.

Authors:  R A Deyo; P Diehr; D L Patrick
Journal:  Control Clin Trials       Date:  1991-08

2.  Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) scale in a rural sample.

Authors:  P Winstead-Fry; A Schultz
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

3.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

4.  Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system.

Authors:  A E Bonomi; D F Cella; E A Hahn; K Bjordal; B Sperner-Unterweger; L Gangeri; B Bergman; J Willems-Groot; P Hanquet; R Zittoun
Journal:  Qual Life Res       Date:  1996-06       Impact factor: 4.147

5.  Validation of the functional assessment of multiple sclerosis quality of life instrument.

Authors:  D F Cella; K Dineen; B Arnason; A Reder; K A Webster; G karabatsos; C Chang; S Lloyd; J Steward; D Stefoski
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

6.  Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

Authors:  M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

7.  Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.

Authors:  P Esper; F Mo; G Chodak; M Sinner; D Cella; K J Pienta
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

8.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

9.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

10.  Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument.

Authors:  D F Cella; A E Bonomi; S R Lloyd; D S Tulsky; E Kaplan; P Bonomi
Journal:  Lung Cancer       Date:  1995-06       Impact factor: 5.705

View more
  12 in total

1.  Validation of the FACT-G scale for evaluating quality of life in cancer patients in Colombia.

Authors:  Ricardo Sánchez; Monica Ballesteros; Benjamin J Arnold
Journal:  Qual Life Res       Date:  2010-10-30       Impact factor: 4.147

Review 2.  Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.

Authors:  David Victorson; Joshua Barocas; Juliette Song; David Cella
Journal:  Qual Life Res       Date:  2008-10-08       Impact factor: 4.147

3.  Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.

Authors:  Cécile Barbaret; Marvin O Delgado-Guay; Stéphane Sanchez; Christelle Brosse; Murielle Ruer; Wadih Rhondali; Léa Monsarrat; Patrick Michaud; Anne Marie Schott; Eduardo Bruera; Marilène Filbet
Journal:  Oncologist       Date:  2019-03-15

4.  Validation of the French version of the colorectal-specific quality-of-life questionnaires EORTC QLQ-CR38 and FACT-C.

Authors:  Christine Rotonda; T Conroy; M Mercier; F Bonnetain; L Uwer; J Miny; P Montcuquet; I Léonard; A Adenis; G Breysacher; F Guillemin
Journal:  Qual Life Res       Date:  2008-03-13       Impact factor: 4.147

5.  Financial distress in patients with advanced cancer.

Authors:  Cécile Barbaret; Christelle Brosse; Wadih Rhondali; Murielle Ruer; Léa Monsarrat; Patrick Michaud; Anne Marie Schott; Marvin Delgado-Guay; Eduardo Bruera; Stéphane Sanchez; Marilène Filbet
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

6.  Assessing whether EORTC QLQ-30 and FACT-G measure the same constructs of quality of life in patients with total laryngectomy.

Authors:  Kamyar Iravani; Peyman Jafari; Allahkaram Akhlaghi; Bijan Khademi
Journal:  Health Qual Life Outcomes       Date:  2018-09-14       Impact factor: 3.186

7.  Physician Empathy Interacts with Breaking Bad News in Predicting Lung Cancer and Pleural Mesothelioma Patient Survival: Timing May Be Crucial.

Authors:  Sophie Lelorain; Alexis Cortot; Véronique Christophe; Claire Pinçon; Yori Gidron
Journal:  J Clin Med       Date:  2018-10-17       Impact factor: 4.241

8.  The effectiveness of a men-only supportive expressive group therapy intervention for psychosocial health outcomes in gastrointestinal cancer patients: a 6-month longitudinal study.

Authors:  Devesh Oberoi; Celestina Martopullo; Barry D Bultz; Linda E Carlson
Journal:  Health Qual Life Outcomes       Date:  2021-02-05       Impact factor: 3.186

9.  Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial.

Authors:  Ariane Mamguem Kamga; Cyril Di Martino; Amelie Anota; Sophie Paget-Bailly; Charles Coutant; Patrick Arveux; Isabelle Desmoulins; Tienhan Sandrine Dabakuyo-Yonli
Journal:  Trials       Date:  2020-06-16       Impact factor: 2.279

10.  Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.

Authors:  Mélanie Dos Santos; Isabelle Hardy-Léger; Olivier Rigal; Idlir Licaj; Sarah Dauchy; Christelle Levy; Sabine Noal; Carine Segura; Corinne Delcambre; Djelila Allouache; Aurélie Parzy; Jérôme Barriere; Thierry Petit; Marie Lange; Aurélie Capel; Bénédicte Clarisse; Jean Michel Grellard; Johan Lefel; Florence Joly
Journal:  Cancer       Date:  2020-09-30       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.